GridAI Technologies (GRDX) Capital Expenditures (2015 - 2021)
GridAI Technologies' (GRDX) quarterly Capital Expenditures came in at -$1960.0 in Q4 2021, down 244.22% YoY from $1359.0 in Q4 2020, and up 20.97% on a QoQ basis from -$2480.0 in Q3 2021.
GridAI Technologies (GRDX) Capital Expenditures (2015 - 2021) Analysis & Trends
GridAI Technologies (GRDX) has 7 years of Capital Expenditures data on file, last reported at -$1960.0 in Q4 2021.
- Quarterly Capital Expenditures fell 244.22% year-over-year to -$1960.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $69488.0 (up 1567.58% YoY) and the FY2021 annual result came in at $69488.0, up 1567.58% from the prior year.
- Capital Expenditures advanced to -$1960.0 in Q4 2021, from -$2480.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $73928.0 in Q2 2021 to a low of -$2480.0 in Q3 2021.
- A 5-year average of $10299.7 and a median of $5597.5 in 2019 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2018 — Capital Expenditures jumped 4946.32% — and 2020, when it slumped 10113.33%.
- Tracing GRDX's Capital Expenditures over 5 years: stood at $215.0 in 2017, then surged by 3208.84% to $7114.0 in 2018, then dropped by 3.64% to $6855.0 in 2019, then sank by 80.18% to $1359.0 in 2020, then slumped by 244.22% to -$1960.0 in 2021.
- The last three Capital Expenditures figures came in at -$1960.0 (Q4 2021), -$2480.0 (Q3 2021), and $73928.0 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 251.02 Mn |
| 10 | GridAI Technologies | 6.37 Mn | 6.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1,960.00 |
| Dec 31, 2021 | -1,960.00 |
| Sep 30, 2021 | -2,480.00 |
| Sep 30, 2021 | -2,480.00 |
| Jun 30, 2021 | 73,928.00 |
| Jun 30, 2021 | 73,928.00 |
| Dec 31, 2020 | 1,359.00 |
| Dec 31, 2020 | 1,359.00 |
| Jun 30, 2020 | -1,532.00 |
| Jun 30, 2020 | -1,532.00 |
| Mar 31, 2020 | 4,340.00 |
| Mar 31, 2020 | 4,340.00 |
| Dec 31, 2019 | 6,855.00 |
| Dec 31, 2019 | 6,855.00 |
| Sep 30, 2019 | 3,906.00 |
| Sep 30, 2019 | 3,906.00 |
| Jun 30, 2019 | -15.00 |
| Jun 30, 2019 | -15.00 |
| Mar 31, 2019 | 13,352.00 |
| Mar 31, 2019 | 13,352.00 |